Argenx
ARGX
#578
Rank
โ‚ฌ33.73 B
Marketcap
559,44ย โ‚ฌ
Share price
0.85%
Change (1 day)
22.02%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚ฌ33.73 Billion

As of November 2024 Argenx has a market cap of โ‚ฌ33.73 Billion. This makes Argenx the world's 578th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚ฌ33.73 B65.24%
2023โ‚ฌ20.41 B4.48%
2022โ‚ฌ19.53 B20.32%
2021โ‚ฌ16.23 B42.44%
2020โ‚ฌ11.39 B85.66%
2019โ‚ฌ6.14 B100.34%
2018โ‚ฌ3.06 B83.42%
2017โ‚ฌ1.67 B
2014โ‚ฌ0.11 B

End of Day market cap according to different sources

On Nov 12th, 2024 the market cap of Argenx was reported to be:

โ‚ฌ33.99 Billion
by Yahoo Finance info icon info icon
โ‚ฌ33.99 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ33.11 Billion
by Nasdaq info icon info icon